How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

To strengthen problem-solving skills and prepare for Software Engineering and AI/ML roles.

Abstract: Recent years have seen a rapid growth in computational methods for a better understanding of functional connectivity brain networks constructed from neuroimaging data. Most of the current ...

Most security teams think of NTFS junctions and symbolic links as niche file system features. They let one directory point to another, like a shortcut that the OS treats as real. They exist for ...

Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

Abstract: In industrial processes, the quality of the product is crucial. The batch partial least squares (PLS) monitoring model can effectively monitor for quality-related faults. In process ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.18, moving -3.34% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.57%.

Sam Altman just said the quiet part out loud. The OpenAI CEO suggested the company could be less than six months away from achieving recursive self-improvement, a capability where AI systems can ...

USA News Group, There is a growing consensus in artificial intelligence that the models themselves are becoming interchangeable, and that ...